Verge Genomics
Verge Genomics is a company focused on the discovery and development of drugs for the treatment of neurodegenerative diseases with the use of machine learning and computational genomics.
5
Funding Rounds
$134.1m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ja*** Ch** | - | - | linkedin twitter |
| Al*** Zh*** | - | - |
Funding
Funding series
Funding Series Analysis
The company Verge Genomics has raised a total of $102.12m in funding over 5 rounds.
Key Insights:
- Verge Genomics Series B round, December 16, 2021: $98m
- Verge Genomics Seed round, October 29, 2015: $4m
- Verge Genomics Seed round, August 18, 2015: $120k
- Verge Genomics funding round, July 2018: $32m
Verge Genomics Series B round, December 16, 2021
$98m
Verge Genomics Seed round, October 29, 2015
$4m
Verge Genomics Seed round, August 18, 2015
$120k
Verge Genomics funding round, July 2018
$32m
Industries
Verge Genomics is active in the following industries:
- Neurotechnology
- Neuroscience
- Drug discovery
- Genomics
- Biomedical engineering
- Bioinformatics
- Biopharmaceutical
- Technology
- Alzheimer's disease
- Parkinson's disease
- Biotechnology
- Biology
- Healthcare
- Medicine
- Neurobiology
- Engineering
- Artificial Intelligence (AI)
- Neurodegenerative Disease